12.1 Safe Medication Administration

The Rights of Medication Administration

Every nurse learns the classic five rights: right patient, right drug, right dose, right route, and right time. Board exams increasingly test the expanded framework, which adds:

• Right documentation — chart after administration, never before
• Right reason — verify the indication matches the patient's condition
• Right response — monitor and document the therapeutic effect and adverse effects
• Right to refuse — patients may decline any medication; educate, then document and notify the provider
• Right education — explain the drug's name, purpose, and side effects before giving it

Some frameworks add right assessment, right evaluation, and right drug–drug interaction check. The exam point: the rights are a minimum standard, not a guarantee — technology and verification processes must back them up.

Verification Layers

Independent Double-Checks

An independent double-check requires two qualified clinicians to separately verify the drug, dose calculation, pump settings, patient, and line attachment before comparing results. It is not independent if one person watches the other work. Organizations typically require independent double-checks for:

• Insulin infusions and subcutaneous dosing
• Anticoagulants (heparin infusions, warfarin loading doses)
• Chemotherapy
• Concentrated electrolytes
• Patient-controlled analgesia (PCA) programming

Barcode Medication Administration (BCMA)

Barcode medication administration requires scanning the patient's wristband and the medication before administration. It catches wrong-patient and wrong-drug errors at the bedside. Workarounds — scanning a wristband taped to the door, scanning after administration — defeat the system and are reportable safety risks. Two patient identifiers (name and date of birth or medical record number) remain mandatory; room number is never an identifier.

Tall-Man Lettering and LASA Drugs

Look-alike/sound-alike (LASA) drug pairs cause thousands of errors yearly. The FDA and Institute for Safe Medication Practices (ISMP) endorse tall-man lettering, capitalizing the distinguishing portion of the name:

Vincristine must never be given intrathecally — it is uniformly fatal and is a classic never-event tested on exams.

ISMP High-Alert Medications

High-alert medications cause significant harm when used in error, even though error rates may not be higher. Highlights of the ISMP list:

• Insulin — the top source of inpatient medication harm; U-100 is standard, but U-500 exists and must never be drawn in a tuberculin syringe
• Anticoagulants — heparin, warfarin, direct oral anticoagulants (DOACs)
• Opioids — especially IV and PCA routes
• Concentrated electrolytes — potassium chloride is never given IV push; it must be diluted and infused, typically no faster than 10 mEq/hour peripherally (20 mEq/hour with cardiac monitoring centrally). Concentrated KCl has been removed from general floor stock for this reason
• Chemotherapy — requires two-clinician verification and specialty competency
• Others: neuromuscular blockers, moderate sedation agents, vasopressors, sodium chloride solutions above 0.9%

Dosage Calculation Safety

Calculation errors kill. Core safeguards:

• No trailing zeros (write 1 mg, never 1.0 mg — a missed decimal makes it 10 mg)
• Always use a leading zero (0.5 mg, never .5 mg)
• Use metric units only; never use household measures or "cc" — write mL
• Recalculate any dose that seems inconsistent with the patient's weight, age, or renal function; question orders outside safe ranges
• Verify pediatric and weight-based doses in mg/kg before giving

Routes and Absorption Basics

Absorption speed: IV > IM > subcutaneous > oral > transdermal. Enteral/oral drugs undergo first-pass metabolism in the liver, reducing bioavailability — sublingual (e.g., nitroglycerin) and transdermal routes bypass this. Food can delay gastric emptying and alter absorption, which is why some drugs are given on an empty stomach (levothyroxine) and others with food (NSAIDs). Transdermal patches (fentanyl) have delayed onset and continued drug delivery after removal — a critical safety point when treating oversedation.

Enteral and Crushing Safety

Many tablets must never be crushed: extended-release products (suffixes like ER, XL, SR, CR), enteric-coated tablets, and sublingual films. Crushing an extended-release opioid delivers the full dose at once — a potentially fatal error. For enteral tubes, give medications individually rather than mixing them together, flush with water before, between, and after each drug, and hold continuous feedings when giving phenytoin. Verify that a liquid formulation is appropriate for the tube, and remember that some IV drugs are lethal by the wrong route (vincristine intrathecally, oral chemotherapy given IV).

Smart Infusion Pumps

Smart pumps contain drug libraries with soft and hard dose limits. A soft alert can be overridden; a hard limit cannot. Safe practice includes programming within the library, never overriding alerts without re-verifying the order, labeling all lines, and performing double-checks on high-alert infusions at every bag change, rate change, and handoff.

Medication Error Response and Reporting

When an error occurs, priorities are:

1. Assess the patient first — monitor vital signs and treat harm; patient safety outranks paperwork
2. Notify the provider and nursing supervisor
3. Document the medication given and the patient's response in the medical record — factually, without using the word "error" in the chart
4. Complete an incident (occurrence) report — a quality-improvement document that is not part of the medical record and is never referenced in the chart

Incident reports operate under a just culture / no-blame model: the goal is system analysis, not punishment. Near-misses are reported too, because they reveal system weaknesses before harm occurs. Failing to report is itself a patient-safety violation.